These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

285 related articles for article (PubMed ID: 12152912)

  • 21. Factors influencing the timing of initiation of renal replacement therapy and choice of modality in children with end-stage kidney disease.
    Favel K; Dionne JM
    Pediatr Nephrol; 2020 Jan; 35(1):145-151. PubMed ID: 31654222
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Kidney Disease: End-Stage Renal Disease.
    Braun MM; Khayat M
    FP Essent; 2021 Oct; 509():26-32. PubMed ID: 34643362
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Extrarenal dialysis in end-stage renal disease].
    Canaud B; Leray-Moragues H; Slingeneyer A
    Rev Prat; 2001 Feb; 51(4):396-403. PubMed ID: 11355604
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Mortality differences between hemodialysis and peritoneal dialysis among ESRD patients in Georgia.
    Tchokhonelidze I
    Georgian Med News; 2007 Feb; (143):27-30. PubMed ID: 17404434
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Racial differences in choice of dialysis modality for children with end-stage renal disease.
    Furth SL; Powe NR; Hwang W; Neu AM; Fivush BA
    Pediatrics; 1997 Apr; 99(4):E6. PubMed ID: 9099781
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Influence of a pre-dialysis education programme (PDEP) on the mode of renal replacement therapy.
    Goovaerts T; Jadoul M; Goffin E
    Nephrol Dial Transplant; 2005 Sep; 20(9):1842-7. PubMed ID: 15919693
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Characteristics of elderly patients with diabetes and end-stage renal disease.
    Goldfarb-Rumyantzev AS; Rout P
    Semin Dial; 2010; 23(2):185-90. PubMed ID: 20374551
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Peritoneal dialysis and kidney transplant. A two-way ticket in an integrated renal replacement therapy model.
    Portolés J; Moreno F; López-Sánchez P; Mancha J; Gómez M; Corchete E; Del Peso G; Bajo MA; Llópez-Carratalá R; Fernández-Perpén A;
    Nefrologia; 2011; 31(4):441-8. PubMed ID: 21738247
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Racial differences in renal replacement therapy initiation among children with a nonglomerular cause of chronic kidney disease.
    Ng DK; Moxey-Mims M; Warady BA; Furth SL; Muñoz A
    Ann Epidemiol; 2016 Nov; 26(11):780-787.e1. PubMed ID: 27789133
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Differences in use of peritoneal dialysis and survival among East Asian, Indo Asian, and white ESRD patients in Canada.
    Hemmelgarn BR; Chou S; Wiebe N; Culleton BF; Manns BJ; Klarenbach S; Khan NA; Gourishankar S; Yeates KE; Gill JS; Tonelli M
    Am J Kidney Dis; 2006 Dec; 48(6):964-71. PubMed ID: 17162151
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Optimizing AVF creation prior to dialysis start: the role of predialysis renal replacement therapy choices.
    Hanko J; Romann A; Taylor P; Copland M; Beaulieu M
    Nephrol Dial Transplant; 2012 Nov; 27(11):4205-10. PubMed ID: 22962410
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Renal replacement therapy in patients with diabetes and end-stage renal disease.
    Locatelli F; Pozzoni P; Del Vecchio L
    J Am Soc Nephrol; 2004 Jan; 15 Suppl 1():S25-9. PubMed ID: 14684667
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prevalence of renal replacement therapy in Veneto for 2008, 2009 and 2010.
    Nordio M; Tessitore N; Feriani M; Rossi B; Amici G; Virga G; Abaterusso C; Antonucci F;
    J Nephrol; 2013; 26 Suppl 20():S13-22. PubMed ID: 24293194
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Survival trends in ESRD patients compared with the general population in the United States.
    van Walraven C; Manuel DG; Knoll G
    Am J Kidney Dis; 2014 Mar; 63(3):491-9. PubMed ID: 24210591
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Nephrology Update: End-Stage Renal Disease and Renal Replacement Therapy.
    Desai N; Rahman M
    FP Essent; 2016 May; 444():23-9. PubMed ID: 27163762
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Treatment of end-stage renal disease in central and eastern Europe: overview of current status and future needs.
    Rutkowski B; Ciocalteu A; Djukanovic L; Kiss I; Kovac A; Polenakovic M; Puretic Z; Rozental R; Stanaityte M; Tareyeva I; Teplan V; Zavitz J; Stefan K; Rado K
    Artif Organs; 1998 Mar; 22(3):187-91. PubMed ID: 9527277
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The treatment of anemia in peritoneal dialysis patients.
    Lacson E; Diaz-Buxo JA
    Clin Nephrol; 2001 Dec; 56(6):415-27. PubMed ID: 11770793
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Comparison of clinical outcomes in peritoneal dialysis and hemodialysis].
    Roob JM
    Wien Klin Wochenschr; 2005; 117 Suppl 6():60-8. PubMed ID: 16437335
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Differential mortality and transplantation rates among Asians and Pacific Islanders with ESRD.
    Hall YN; Sugihara JG; Go AS; Chertow GM
    J Am Soc Nephrol; 2005 Dec; 16(12):3711-20. PubMed ID: 16236803
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Survey on the current status of delivered informed consent for renal replacement therapy among patients with end-stage renal disease].
    Nakano H; Koga S; Nakamoto H; Nakayama M; Hiramatsu M; Masakane I
    Nihon Jinzo Gakkai Shi; 2006; 48(7):658-63. PubMed ID: 17128882
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.